Cardica, Inc.  

(Public, NASDAQ:CRDC)   Watch this stock  
Find more results for CRDC
1.28
-0.02 (-1.54%)
May 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.25 - 1.30
52 week 0.67 - 1.99
Open 1.27
Vol / Avg. 0.00/49,340.00
Mkt cap 47.30M
P/E     -
Div/yield     -
EPS -0.44
Shares 36.95M
Beta 1.08
Inst. own 63%
Aug 2, 2013
Q4 2013 Cardica, Inc. Earnings Release Add to calendar
May 1, 2013
Q3 2013 Cardica, Inc. Earnings Release
Apr 30, 2013
Q3 2013 Cardica, Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin -479.63% -368.79%
Operating margin -466.82% -361.75%
EBITD margin - -338.44%
Return on average assets -126.05% -91.69%
Return on average equity -265.23% -134.26%
Employees 62 -
Carbon Disclosure Rating - -

Address

900 Saginaw Drive
REDWOOD CITY, CA 94063
United States - Map
+1-650-3649975 (Phone)
+1-650-3643134 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Cardica, Inc. (Cardica) is focused on the development of an endoscopic microcutter product line intended for use by thoracic, bariatric, colorectal and general surgeons. The first product that it is developing in its microcutter product line is the Microcutter XPRESS 30, the multi-fire endolinear microcutter device based on its staple-on-a-strip technology. In addition, the Company is developing the Microcutter XPRESS 45, a multi-fire endolinear microcutter device with a 45 millimeter staple line, the Microcutter XCHANGE 30, a cartridge based microcutter device with a 5 millimeter shaft diameter and a 30 millimeter staple line, the Microcutter FLEXCHANGE 30, a cartridge based microcutter device with a flexible shaft to facilitate endoscopic procedures requiring cutting and stapling, and the Microcutter XPRESS 60, a cutting and stapling device specifically designed for the bariatric and thoracic surgery markets.

Officers and directors

Kevin T. Larkin Independent Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Bernard A. Hausen M.D., Ph.D. President, Chief Executive Officer, Chief Medical Officer, Director
Age: 52
Bio & Compensation  - Reuters
Robert Y. Newell Chief Financial Officer, Vice President - Finance
Age: 64
Bio & Compensation  - Reuters
Frederick M. Bauer Vice President - Operations
Age: 58
Bio & Compensation  - Reuters
Christopher J. Littel Vice President - Sales and Marketing
Age: 56
Bio & Compensation  - Reuters
Bryan D. Knodel Ph.D. Vice President - Research & Development
Age: 52
Bio & Compensation  - Reuters
Richard P. Powers Independent Director
Age: 68
Bio & Compensation  - Reuters
Jeffrey L. Purvin Independent Director
Age: 60
Bio & Compensation  - Reuters
John Simon Ph.D. Independent Director
Age: 58
Bio & Compensation  - Reuters
William H. Younger Jr. Independent Director
Age: 62
Bio & Compensation  - Reuters